返回 Agenda
Session Chair(s)
Nermeen Y. Varawalla
Executive Vice President, Global Clinical Trials
Lambda Therapeutic Research, United Kingdom
Learning Objective : Understand the distinction between the learn and confirm phases of drug development Recognise designs appropriate to each phase
Speaker(s)
The Learning/ Confirming Continuum and Adaptive Designs.
Andrew Peter Grieve, DRSC, PHD, MSC
Aptiv Solutions, Germany
Senior Vice President Clinical Trial Methodology
Recent Advances in Adaptive Clinical Trial Designs for Medical Writers
William K. Sietsema, PHD
Caladrius Biosciences, Inc., United States
Executive Director, Global Regulatory Affairs
Multi-Centre Early Phase Cohort Studies: Lessons for conducting adaptive trials
Andreas Geissler, MS, PMP
PAREXEL International, Germany
Director Client Services, RTSM Division